Compare Vaxcyte Inc. Common Stock (PCVX) vs Veralto Corp Common Stock (VLTO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Veralto Corp Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while Veralto Corp Common Stock trades at $101.5 (market cap $24.13B). The key difference: Veralto Corp Common Stock is far larger — about 2.3× Vaxcyte Inc. Common Stock's market cap, and Veralto Corp Common Stock pays a 0.53% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Veralto Corp Common Stock for 0 Days on average.
| PCVX | VLTO | |
|---|---|---|
Market Cap | $10.51B | $24.13B |
Volume | 2,644,694 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $73.82 | $104.87 |
52-Week Low | $40.32 | $82.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $25.39B |
Dividend Yield | — | 0.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Veralto Corp Common Stock
Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →
